0001140361-16-080344.txt : 20160920
0001140361-16-080344.hdr.sgml : 20160920
20160920181220
ACCESSION NUMBER: 0001140361-16-080344
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160916
FILED AS OF DATE: 20160920
DATE AS OF CHANGE: 20160920
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNERGY PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001347613
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330505269
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE
STREET 2: SUITE 2012
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: 212-297-0010
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE
STREET 2: SUITE 2012
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Synergy Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20080812
FORMER COMPANY:
FORMER CONFORMED NAME: PAWFECT FOODS INC
DATE OF NAME CHANGE: 20051221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAULSON & CO. INC.
CENTRAL INDEX KEY: 0001035674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35268
FILM NUMBER: 161894634
BUSINESS ADDRESS:
STREET 1: 1251 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 212-956-2221
MAIL ADDRESS:
STREET 1: 1251 AVENUE OF THE AMERICAS
CITY: NEW YORK
STATE: NY
ZIP: 10020
FORMER NAME:
FORMER CONFORMED NAME: PAULSON & CO INC
DATE OF NAME CHANGE: 19970313
4
1
doc1.xml
FORM 4
X0306
4
2016-09-16
0
0001347613
SYNERGY PHARMACEUTICALS, INC.
SGYP
0001035674
PAULSON & CO. INC.
1251 AVENUE OF THE AMERICAS
NEW YORK
NY
10020
0
0
1
0
Common stock, par value of $.0001
2016-09-16
4
S
0
1973713
5.6113
D
25782955
I
By Managed Funds and Accounts
Common stock, par value of $.0001
2016-09-19
4
S
0
1500000.00
5.6100
D
24282955.00
I
By Managed Funds and Accounts
Paulson & Co. Inc. ("Paulson") is an investment advisor registered under the Investment Advisors Act of 1940. Paulson is the investment manager of investment funds (the "Funds") and certain separately managed accounts (the "Separately Managed Accounts"). John Paulson is the controlling person of Paulson. All securities reported on this Form 4 are owned by the Funds or held in the Separately Managed Accounts.
Each of Paulson and John Paulson may be deemed to indirectly beneficially own the securities directly owned by the Funds or held in the Separately Managed Accounts. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the filing of this Form 4 shall not be deemed an admission by any person reporting on this Form 4 that such person, for purposes of Section 16 of the Act or otherwise, is the beneficial owner of any equity securities covered by this Form 4.
/s/ Stuart L. Merzer, General Counsel & Chief Compliance Officer
2016-09-20